Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmNeoplasmsBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticFossilsAnthracyclinesFollow-Up StudiesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungHistory, AncientTime FactorsOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsVomitingAdenocarcinomaNeutropeniaTransplantation, AutologousRadiotherapy, AdjuvantHodgkin DiseaseNauseaLymphoma, Non-HodgkinHominidaeAntineoplastic Agents, PhytogenicRadiotherapyColorectal NeoplasmsClinical Trials as TopicProspective StudiesAntibiotics, AntineoplasticDacarbazineNeoplasms, Germ Cell and EmbryonalCarmustineKaplan-Meier EstimateLomustineBrain NeoplasmsGranulocyte Colony-Stimulating FactorCamptothecinPlatinum CompoundsBone NeoplasmsDrug TherapyInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinLiver NeoplasmsTumor Markers, BiologicalThiotepaHematopoietic Stem Cell TransplantationRecurrencePeritoneal NeoplasmsLymphatic MetastasisMitoxantroneInfusions, IntravenousPalliative CareDose-Response Relationship, DrugRadiotherapy DosageStomach NeoplasmsAntibodies, Monoclonal, HumanizedTegafurCell Line, TumorGerminomaRandomized Controlled Trials as TopicPaleontologyDaunorubicinCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma